This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
From basic skincare routines to targeted treatments and product recommendations, I’m here to provide you with expert advice that is both informative and educational. Emerging technology has afforded us the luxury of ingredients and treatments from around the globe, challenging us to balance traditional wisdom with progressive science.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization in Great Britain for delgocitinib cream (Anzupgo, Leo Pharma) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.
These treatments are a natural fit for dental practices that focus on facial aesthetics, as they can complement smile makeovers, helping patients achieve a youthful, refreshed appearance that extends beyond their teeth. Botox®) and dermal fillers, as part of their cosmetic dentistry offerings.
The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. immunology market.” “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb).
A microcurrent facial is a treatment that uses low-level electrical currents to stimulate the muscles and the skin. Microcurrent facials are one of my favorite treatments to perform because they offer so many benefits for the skin! At Kim Gallo Esthetics, your comfort and safety is our top priority.
Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Restem’s umbilical cord outer lining stem cells (ULSCs) program for the treatment of dermatomyositis (DM) and polymyositis (PM). The estimated incidence of PM/DM is approximately 5 to 22 cases per 100,000 individuals. PHOTO CREDIT: DermNet The post U.S.
Patients today seek treatments that offer impressive results with minimal downtime, making these procedures a must-know for practitioners aiming to stay ahead of the curve. Why Non-Surgical Treatments Are on the Rise Non-surgical cosmetic procedures are transforming the landscape of aesthetic medicine.
first pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) trial of Xyngari, a novel, once-weekly, topical product candidate for the treatment of moderate-to-severe acne. The XYNGARI Phase 3 STAR-1 clinical study will evaluate the efficacy, safety, and tolerability of Xyngari in patients with moderate-to-severe facial acne.
Food and Drug Administration (FDA) approved mirdametinib (Gomekli, SpringWorks) for the treatment of adult and pediatric patients aged two and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that are not amenable to complete resection. Gomekli is an oral, small molecule MEK inhibitor.
Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. Having daily and weekly communication when dealing with patients receiving treatment is critical.
Heres why it appeals to so many medical professionals: High Demand: Patients are increasingly seeking non-invasive cosmetic treatments, creating a steady demand for trained practitioners. Understanding patient safety protocols and treatment planning. Aesthetic medicine is one of the fastest-growing fields in healthcare.
.” The Unbeatable Performance campaign will feature Maher in a variety of content, including a modern recreation of the brand’s beloved girl-and-dog pose used on product packaging and in the brand’s marketing. The campaign will also include social media and online video.
Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Incyte is investigating the efficacy and safety of ruxolitinib cream in cutaneous lichen planus.
Unlike large laser companies that spend millions on marketing with big events, influencer partnerships, and doctor endorsements, we avoid these costly strategies, which often contribute to significant price markups. Question Which of your lasers offers a “pain-free” experience for the client?
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.
While the most common deceitful practice is the use of counterfeit (fake) Botox or dermal fillers, other concerns include the use of outdated treatments and surgical techniques or the promise of unrealistic results. This comprehensive guide will help you recognize red flags, ask the right questions, and prioritize your safety.
Peels are one of the most useful tools in a skin care professional's arsenal, but they must be used correctly to ensure not only efficacy but also safety. TCA peels are commonly used by physicians as a medium-depth peeling treatment due to its effect on collagen stimulation and skin tightening. The skin has a pH of approximately 4.5-5,
The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s s botulinum toxin product Letybo is coming to the U.S.
Food and Drug Administration (FDA) and Marketing Authorization Application (MAA) in the UK and EU for CORDStrom in Recessive Dystrophic Epidermolysis Bullosa (RDEB). This trial showed a favorable benefit-risk profile in support of the intended applications for marketing authorization. INmune Bio, Inc.
Non-invasive body contouring treatments have gained immense popularity due to their ability to target stubborn fat, tighten skin, and improve body shape all without the need for invasive procedures. Non-invasive body contouring refers to treatments that reduce fat, tighten skin, and reshape targeted areas of the body without surgery.
Magic Sleek is the first and only hair care brand on the market that has been approved by the Occupational Safety and Health Administration (OSHA), Food and Drug Administration (FDA) and European Union (EU).
Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN. Food and Drug Administration for the treatment of AD and PN.
Food and Drug Administration (FDA) has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use as a biosimilar to Stelara for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older. Market Access at Teva, in a news release.
Additionally, automated communication tools keep clients engaged and informed throughout their treatment journey, improving satisfaction and loyalty. This seamless integration of technology ensures that every aspect of the client experience is considered and optimized, from the initial consultation to post-treatment care.
Vyjuvek (beremagene geperpavec-svdt, or B-VEC) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. approved by the EC, the Company expects to market B-VEC under the registered European trademark, Vyjuvek.
The Clinical Aesthetics Certification is 70 hours of continuing education units (CEU) and ideal for professionals aiming to work in medical spas, dermatology clinics, or with advanced skincare treatments. The curriculum includes: Combining the best of clinical and medspa treatments including microneedling, MRF, nanochanneling and more.
This non-invasive treatment uses advanced laser technology to target hair follicles, reducing regrowth and delivering lasting results. It is the most advanced laser technology on the market that can safely treat skin types I-VI. Proper training and expertise are crucial to ensure your safety and the best possible results.
Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). The FDA has granted nemolizumab Priority Review for prurigo nodularis.
Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to Abeona’s Biologics License Application (BLA) for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa (RDEB).
The Beauty Brains episode 182 – we cover beauty questions about BB glow facials The safety of self tanners Doing you own research and Hard water and your beauty products Beauty Science News Butt Masks Is natural deodorant necessary ? So, with the uncertain safety profile and the limited benefit I’m not sure I can recommend doing this.
Enter Percutaneous Collagen Induction (PCI) – a transformative treatment that’s catching the eyes of dermatologists and patients alike. microneedling market has seen a consistent upward trajectory since 2020, translating to more informed and effective treatments by practitioners. With Acne being a prime concern, the U.S.
Each day, you strive to provide your clients with exceptional experiences that leave them feeling incredibly happy with the results of products and treatments. This information forms the basis for creating personalized treatment plans. Impeccable Hygiene and Safety Hygiene and safety are non-negotiable in our industry.
Sonelokimab is a novel investigational nanobody for the treatment of inflammatory disease. Marketing Authorization Application. European Medicines Agency (EMA) have greenlighted MoonLake Immunotherapeutics’ Phase 3 Program for the nanobody sonelokimab (SLK) in hidradenitis suppurativa (HS).
As the demand for non-surgical cosmetic treatments like Botox and dermal fillers continues to rise, the need for skilled professionals who can administer these procedures safely and effectively is greater than ever. Safety and Ethical Practices: Nima places a strong emphasis on safety and ethical practices in Botox and filler administration.
Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”
Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces. This adaptability is ideal for residential spas seeking to optimize their treatment offerings while catering to varying client needs.
1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS.
The Dos And Don'ts Of Facial Steaming Written By (old): Libby Wright Are you looking for a luxurious facial treatment that you can do between your visits to the spa? These days, there are a lot of facial steamers on the market, but you can also DIY at home with a big bowl or sink of warm water and a towel. What Is Facial Steaming?
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion and recommended granting marketing authorization for nemolizumab (Nemluvio. Galderma) for the treatment of both atopic dermatitis and prurigo nodularis in the European Union (EU).
The Dos And Don'ts Of Facial Steaming Written By: Libby Wright Are you looking for a luxurious facial treatment that you can do between your visits to the spa? These days, there are a lot of facial steamers on the market, but you can also DIY at home with a big bowl or sink of warm water and a towel. What Is Facial Steaming?
Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.
Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. This marks the fourth FDA-approved biosimilar for Stelara. and worldwide.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content